United States HR 1352: Increasing Access to Biosimilars Act of 2023

Status: Referred to the Subcommittee on Health. (as of 2024-12-17)

State: United States · Session: 118 · Bill: HR 1352

Sponsors: Richard Hudson

View United States HR 1352 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.